Angel Biotechnology Holdings (LSE:ABH) Receivables Turnover: 0.00 (As of Sep. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Angel Biotechnology Holdings Receivables Turnover?

Angel Biotechnology Holdings LSE:ABH Receivables Turnover is 0.00 as of Sep. 2012. The stock has 2 warning signs investors should review.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Angel Biotechnology Holdings's Revenue for the six months ended in Sep. 2012 was £1.07 Mil. Angel Biotechnology Holdings's average Accounts Receivable for the six months ended in Sep. 2012 was £0.00 Mil.

Angel Biotechnology Holdings  (LSE:ABH) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Angel Biotechnology Holdings Receivables Turnover Related Terms

Angel Biotechnology Holdings Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings Receivables Turnover Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Angel Biotechnology Holdings Receivables Turnover Competitor Comparison

For the Biotechnology subindustry, Angel Biotechnology Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angel Biotechnology Holdings Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Angel Biotechnology Holdings's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Angel Biotechnology Holdings's Receivables Turnover falls into.


Angel Biotechnology Holdings Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Angel Biotechnology Holdings's Receivables Turnover for the fiscal year that ended in Mar. 2012 is calculated as

Receivables Turnover (A: Mar. 2012 )
=Revenue / Average Accounts Receivable
=Revenue (A: Mar. 2012 ) / ((Accounts Receivable (A: Dec. 2010 ) + Accounts Receivable (A: Mar. 2012 )) / count )
=3.456 / ((0 + 0) / 1 )
=3.456 / 0
=N/A

Angel Biotechnology Holdings's Receivables Turnover for the quarter that ended in Sep. 2012 is calculated as

Receivables Turnover (Q: Sep. 2012 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Sep. 2012 ) / ((Accounts Receivable (Q: Mar. 2012 ) + Accounts Receivable (Q: Sep. 2012 )) / count )
=1.07 / ((0 + 0) / 1 )
=1.07 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Angel Biotechnology Holdings (LSE:ABH) has a Receivables Turnover of 0.00 as of Sep. 2012. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' Receivables Turnover too high?
Angel Biotechnology Holdings' current Receivables Turnover is 0.00.
How does Angel Biotechnology Holdings' Receivables Turnover compare to competitors?
Angel Biotechnology Holdings' Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.27, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Angel Biotechnology Holdings and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angel Biotechnology Holdings's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current Receivables Turnover is 0.00 as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.